LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Subscribe To Our Newsletter & Stay Updated
